Keywords: Contrast Agents, Contrast Agent, pH sensor, temperature sensor, transition metal complex, MRSI, early cancer detection
Motivation: Gadolinium based contrast agents (GBCAs) are reported to be toxic and associated with nephrogenic systemic fibrosis (NSF). Alternative options should be developed to minimize toxicity.
Goal(s): Develop alternative biocompatible transition metal-based MRI agents for advanced imaging.
Approach: Using paramagnetic high spin Fe(II), Co(II), and Ni(II) ions coordinated with well-established cyclic ligands for enhanced MRS imaging to detect cancer tumors at an early stage.
Results: Fe(II)DOTA-4AmC2-, Co(II)DOTA-4AmC2-, and Ni(II)DOTA-4AmC2- were synthesized and characterized. Their in vitro pH and temperature sensing capabilities were assessed using BIRDS at 11.7T.
Impact: These biocompatible pH sensors can be employed for in vivo pH mapping for early cancer diagnosis and can also be adapted for clinical applications.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords